REGISTERED NUMBER: 06478504 (England and Wales)

Unaudited Financial Statements

for the Year Ended 31 March 2025

for

GLENFIELD PHARMACY LTD

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTORS:

Dr N Chotai

Mr T R Nawaz

Dr J W Trayner

SECRETARY:

Mr T R Nawaz

REGISTERED OFFICE:

6 Knowle Green

Dore

Sheffield

S17 3AP

REGISTERED NUMBER:

06478504 (England and Wales)

ACCOUNTANTS:

Brown McLeod Limited

Chartered Accountants

The Old Workshop

1 Ecclesall Road South

Sheffield

South Yorkshire

S11 9PA

FIXED ASSETS

Tangible assets

4

74,812

83,945

CURRENT ASSETS

Stocks

112,212

78,672

Debtors

5

367,891

247,816

Cash at bank and in hand

720,008

601,338

1,200,111

927,826

CREDITORS

Amounts falling due within one year

6

401,584

313,187

NET CURRENT ASSETS

798,527

614,639

TOTAL ASSETS LESS CURRENT LIABILITIES

873,339

698,584

CAPITAL AND RESERVES

Called up share capital

120

120

Retained earnings

873,219

698,464

SHAREHOLDERS' FUNDS

873,339

698,584

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 13 December 2025 and were signed on its behalf by:

Mr T R Nawaz - Director

1.	STATUTORY INFORMATION

Glenfield Pharmacy Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery

-

25% on reducing balance

Fixtures and fittings

-

20% on reducing balance

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 6 (2024 - 6 ) .

4.	TANGIBLE FIXED ASSETS

Plant and

Land and

machinery

buildings

etc

Totals

£

£

£

COST

At 1 April 2024

77,220

49,560

126,780

Additions

-

2,950

2,950

At 31 March 2025

77,220

52,510

129,730

DEPRECIATION

At 1 April 2024

7,723

35,112

42,835

Charge for year

7,722

4,361

12,083

At 31 March 2025

15,445

39,473

54,918

NET BOOK VALUE

At 31 March 2025

61,775

13,037

74,812

At 31 March 2024

69,497

14,448

83,945

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.25

31.3.24

£

£

Trade debtors

277,533

175,675

Other debtors

90,358

72,141

367,891

247,816

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.25

31.3.24

£

£

Trade creditors

328,234

262,805

Taxation and social security

65,949

35,268

Other creditors

7,401

15,114

401,584

313,187

7.	ULTIMATE CONTROLLING PARTY

The controlling party is the directors acting in concert.